TransMedics Group

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade TransMedics Group 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About TMDX

TransMedics Group, Inc. operates as a commercial stage medical technology company. The firm engages in the development and commercialization of organ care system platform. 

CEO
Waleed H. Hassanein
CEOWaleed H. Hassanein
Employees
728
Employees728
Headquarters
Andover, Massachusetts
HeadquartersAndover, Massachusetts
Founded
1998
Founded1998
Employees
728
Employees728

TMDX Key Statistics

Market cap
5.14B
Market cap5.14B
Price-Earnings ratio
57.64
Price-Earnings ratio57.64
Dividend yield
Dividend yield
Average volume
648.82K
Average volume648.82K
High today
$144.23
High today$144.23
Low today
$136.00
Low today$136.00
Open price
$141.00
Open price$141.00
Volume
921.23K
Volume921.23K
52 Week high
$156.00
52 Week high$156.00
52 Week low
$55.00
52 Week low$55.00

Stock Snapshot

With a market cap of 5.14B, TransMedics Group(TMDX) trades at $138.50. The stock has a price-to-earnings ratio of 57.64.

During the trading session on 2026-01-14, TransMedics Group(TMDX) shares reached a daily high of $144.23 and a low of $136.00. At a current price of $138.50, the stock is +1.8% higher than the low and still -4.0% under the high.

Trading activity shows a volume of 921.23K, compared to an average daily volume of 648.82K.

The stock's 52-week range extends from a low of $55.00 to a high of $156.00.

The stock's 52-week range extends from a low of $55.00 to a high of $156.00.

TMDX News

TipRanks 9h
TransMedics’ DENOVO Trial: New Lung Preservation Study Could Shape Future Growth for TMDX

Transmedics Group (TMDX) announced an update on their ongoing clinical study. Claim 70% Off TipRanks Premium Unlock hedge fund-level data and powerful investing...

Simply Wall St 1d
Assessing TransMedics Group Valuation After New Headquarters And Campus Expansion Commitment

TransMedics Group (TMDX) has committed to a long-term lease for a new global headquarters at Assembly Innovation Park in Somerville, and it has acquired adjacen...

Assessing TransMedics Group Valuation After New Headquarters And Campus Expansion Commitment

Analyst ratings

77%

of 13 ratings
Buy
76.9%
Hold
23.1%
Sell
0%

People also own

Based on the portfolios of people who own TMDX. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the .